Enhanced nanoparticle delivery exploiting tumour-responsive formulations

Abstract Nanoparticles can be used as drug carriers, contrast agents and radiosensitisers for the treatment of cancer. Nanoparticles can either passively accumulate within tumour sites, or be conjugated with targeting ligands to actively enable tumour deposition. With respect to passive accumulation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lindsey A. Bennie, Helen O. McCarthy, Jonathan A. Coulter
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2018-11-01
Colecção:Cancer Nanotechnology
Assuntos:
Tumour microenvironment
Nano-therapeutics
Gold nanoparticles
Cell-penetrating peptide
Cleavable stealth molecules
Nucleic acids
Acesso em linha:http://link.springer.com/article/10.1186/s12645-018-0044-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados